PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer

Running, not enrolling · Not applicable

Conditions studied: Malignant Ovarian Neoplasm, Ovarian Carcinoma

In brief

This trial studies how well positron emission tomography/magnetic resonance (PET/MR) versus contrast enhanced computerized tomography (CECT) scans work in locating ovarian cancer tumors in patients with known or suspected ovarian cancer. PET, MR, and CECT scans use different methods to create images of areas inside the body. This trial is being done to see if PET/MR scans may help doctors locate ovarian cancer tumors, predict how well these tumors may be removed during surgery, and predict how patients respond to platinum-based chemotherapies compared to standard of care CECT scans.

Key facts

Study ID

NCT03965481

Run by

M.D. Anderson Cancer Center

People needed

21

Starts

2018-05-12

Expected to finish

2027-04-30

Last updated by the study team

2026-04-15

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients with ovarian cancer or highly suspected ovarian cancer who are eligible to undergo laparoscopic evaluation for resectability will be enrolled in the trial.
• Patients who have estimated glomerular filtration rate (eGFR) > 30.

You may not qualify if…

• Patients allergic to gadolinium.
• Patients who have eGRF < 30.
• Patients with cardiac pacers.
• Pediatric patients.
• Greater than 400 pounds in weight.
• Blood glucose (> 200 mg/dl).
• Pregnant women.

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.